MedDataX Logo

Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP

NCT04167592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-11-19

No results posted yet for this study

Summary

It was a study aimed to determine the effectivity of benzydamine hydrochloride gargling in reducing propofol consumption in the Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.

Conditions

  • ERCP

Interventions

DRUG

Benzydamine Hydrochloride 0.15% Oral Rinse

Benzydamine Hydrochloride 0.15% Oral Rinse was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.

DRUG

Water

Water was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Adhrie Sugiarto, MD · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2018-09-01
Completion
2018-10-01

Countries

  • Indonesia

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167592 on ClinicalTrials.gov